Wnt antagonism in multiple myeloma: a potential cause of uncoupled bone remodeling.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17062713.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bone disease in patients with multiple myeloma (MM) is characterized by uncoupled bone remodeling, evident as enhanced osteolytic resorption and decreased rather than increased bone formation. MM-triggered osteolysis follows deregulation of the receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin cytokine axis. Inhibition of bone formation may result from the ability of MM to inhibit the function of Wnts, secreted glycoproteins critical to osteoblast development. Recent studies show how these processes may be linked.
Medical subject headings
- Bone Remodeling
- Multiple Myeloma
- Signal Transduction
- Wnt Proteins